Inflammasomes are important regulators of immunity and inflammatory diseases, making NLRP3 one of the most attractive targets for the development of innovative therapeutic approaches due to its association with several human inflammatory and autoimmune diseases [1,2,3,4]. This evidence concerns the gene NLRP3 and autoimmune disease.